Recent studies have identified calpain 2 as an actor of the resistance of colorectal cancer cells to irinotecan [16], we have thus studied the potential implication of ubiquitous calpains in the resistance to oxaliplatin. This evidence concerns the gene CAPN2 and colorectal cancer.